Determinants of Streptococcus pyogenes fitness in the female primate genital tract: A genome-wide analysis
Determinants of Streptococcus pyogenes fitness in the female primate genital tract: A genome-wide analysis
批准号:
9805040
负责人:
James MALLORY Musser
金额:
$20.19万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-06-01 至 2021-05-31
关键词:
AddressAnatomyAnimalsBacterial GenesBasic ScienceBindingBiologyBloodCandidate Disease GeneClinicalComplementDataDiagnosisDiseaseEnvironmentEpidemicEpitheliumEventFemaleFutureGene SilencingGenesGenomeGoalsGoldHumanIn VitroIndividualInfectionKnowledgeLibrariesMacacaMedicineMethodsModelingMolecularMonitorMorbidity - disease rateMotivationMouse StrainsMucous MembraneMutagenesisMyositisNecrotizing fasciitisNeonatalOrganismPathogenesisPharyngitisPhasePhylogenetic AnalysisPrimatesProcessPuerperal InfectionPuerperal pyrexiaRecording of previous eventsReportingResearchResearch ActivityRoleSalivaSepsisSepticemiaSerotypingSeveritiesSiteStreptococcus pyogenesSurfaceTargeted ResearchTechnologyTimeTranslational ResearchVaccinesVaginaVirulenceVirulence FactorsWorkbasedesignexperiencefitnessgene productgenome sequencinggenome wide screengenome-widegenome-wide analysishuman diseasehuman pathogenin vivoinnovationinterestknockout genemortalitymouse modelmucosal sitemutantneonatal sepsisnonhuman primatenovelpathogenpathogenic bacteriapreventreproductive tractsubcutaneoussuccesstooltranscriptometranscriptome sequencingtranslational approachvaccine candidate
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The human bacterial pathogen Streptococcus pyogenes (group A streptococcus, GAS) causes more than
700 million human infections annually worldwide. The proposed research seeks to discover, on a genome-
wide scale, GAS genes required for, or contributing to fitness in the female genital tract, an infection site for
which very little basic understanding is known. We will use a serotype M28 GAS strain because for reasons
that aren’t understood, these organisms are non-randomly associated with female genital tract disease,
including puerperal sepsis (childbed fever) and neonatal invasive infections. The pathogen genes and
fundamental molecular pathogenesis processes contributing to two phases of genital tract interaction will be
studied: (i) colonization and proliferation and (ii) persistence. This basic science knowledge deficit has
severely limited the ability to create new clinical tools such as a successful GAS vaccine. Thus, the studies
are designed to address this critical knowledge deficit. We will combine our very recent success in applying
transposon-directed insertion site sequencing (TraDIS) technology to GAS with our 18 years of productive
experience with cynomolgus macaque models of GAS infection, currently the gold standard experimental
animal to study this human pathogen. We will use TraDIS to conduct an in vivo genome-wide screen that will
systematically identify GAS genes required for colonization and proliferation, and persistence in the genital
tract of female cynomolgus macaques. The goal of the proposed studies is to identify new molecular
mechanisms used by GAS to enhance fitness in this anatomic niche. The results of our studies may ultimately
help in formulating novel translational strategies to prevent or treat GAS infections. To achieve our goals, the
following two specific aims are proposed: Specific Aim 1: Exploit TraDIS for genome-wide identification of
GAS genes required for (i) colonization and proliferation, and (ii) persistence (i.e., fitness) in the genital tract
of female cynomolgus macaques. Specific Aim 2: Use isogenic gene-knockout mutant strains to validate the
importance of four selected candidate genes to GAS colonization and proliferation, and persistence identified
by the genome-wide screen. The proposed line of research will exploit our innovative and successful
application of TraDIS to GAS, including infections in cynomolgus macaques. It will be the first use of TraDIS
in the genital tract of female non-human primates and the first study to investigate determinants of GAS
colonization and proliferation, and persistence, on a mucosal surface using genome-wide transposon
mutagenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular basis of decreased susceptibility to beta-lactam antibiotics in Streptococcus pyogenes
-
批准号:10596614
-
项目类别:
-
资助金额:$16.15万
-
财政年份:2022
-
负责人:James MALLORY Musser
-
依托单位:
Molecular basis of decreased susceptibility to beta-lactam antibiotics in Streptococcus pyogenes
-
批准号:10449481
-
项目类别:
-
资助金额:$28.26万
-
财政年份:2022
-
负责人:James MALLORY Musser
-
依托单位:
Novel Determinants of Streptococcus Pyogenes Virulence and Protective Immunity in the Primate Oropharynx: A Genome-wide Strategy
-
批准号:10387431
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2021
-
负责人:James MALLORY Musser
-
依托单位:
NOVEL GROUP A STREPTOCOCCUS HUMAN VACCINE CANDIDATES
-
批准号:7113176
-
项目类别:
-
资助金额:$68.92万
-
财政年份:2004
-
负责人:James MALLORY Musser
-
依托单位:
NOVEL GROUP A STREPTOCOCCUS HUMAN VACCINE CANDIDATES
-
批准号:7493506
-
项目类别:
-
资助金额:$68.67万
-
财政年份:2004
-
负责人:James MALLORY Musser
-
依托单位:
NOVEL GROUP A STREPTOCOCCUS HUMAN VACCINE CANDIDATES
-
批准号:7283635
-
项目类别:
-
资助金额:$70.14万
-
财政年份:2004
-
负责人:James MALLORY Musser
-
依托单位:
NOVEL GROUP A STREPTOCOCCUS HUMAN VACCINE CANDIDATES
-
批准号:6931521
-
项目类别:
-
资助金额:$65.03万
-
财政年份:2004
-
负责人:James MALLORY Musser
-
依托单位:
NOVEL GROUP A STREPTOCOCCUS HUMAN VACCINE CANDIDATES
-
批准号:6804318
-
项目类别:
-
资助金额:$64.48万
-
财政年份:2004
-
负责人:James MALLORY Musser
-
依托单位:
GENETIC EPIDEMIOLOGY OF TUBERCULOSIS SUSCEPTIBILITY
-
批准号:2672974
-
项目类别:
-
资助金额:$48.06万
-
财政年份:1997
-
负责人:James MALLORY Musser
-
依托单位:
GENETIC EPIDEMIOLOGY OF TUBERCULOSIS SUSCEPTIBILITY
-
批准号:2005705
-
项目类别:
-
资助金额:$48.27万
-
财政年份:1997
-
负责人:James MALLORY Musser
-
依托单位:
TUBERCULOSIS SPREAD IN DRUG USERS
-
批准号:2377403
-
项目类别:
-
资助金额:$101.95万
-
财政年份:1995
-
负责人:James MALLORY Musser
-
依托单位:
TUBERCULOSIS SPREAD IN DRUG USERS
-
批准号:2882598
-
项目类别:
-
资助金额:$107.74万
-
财政年份:1995
-
负责人:James MALLORY Musser
-
依托单位:
TUBERCULOSIS SPREAD IN DRUG USERS
-
批准号:2122334
-
项目类别:
-
资助金额:$104.87万
-
财政年份:1995
-
负责人:James MALLORY Musser
-
依托单位:
TUBERCULOSIS SPREAD IN DRUG USERS
-
批准号:2668148
-
项目类别:
-
资助金额:$103.91万
-
财政年份:1995
-
负责人:James MALLORY Musser
-
依托单位:
TUBERCULOSIS SPREAD IN DRUG USERS
-
批准号:2122333
-
项目类别:
-
资助金额:$106.73万
-
财政年份:1995
-
负责人:James MALLORY Musser
-
依托单位:
TUBERCULOSIS--DEVELOPMENT OF DNA BASED DIAGNOSTICS
-
批准号:2073580
-
项目类别:
-
资助金额:$36.12万
-
财政年份:1994
-
负责人:James MALLORY Musser
-
依托单位:
TUBERCULOSIS--DEVELOPMENT OF DNA BASED DIAGNOSTICS
-
批准号:2327244
-
项目类别:
-
资助金额:$6.88万
-
财政年份:1994
-
负责人:James MALLORY Musser
-
依托单位:
TUBERCULOSIS--DEVELOPMENT OF DNA BASED DIAGNOSTICS
-
批准号:2073579
-
项目类别:
-
资助金额:$29.92万
-
财政年份:1994
-
负责人:James MALLORY Musser
-
依托单位:
TUBERCULOSIS--DEVELOPMENT OF DNA BASED DIAGNOSTICS
-
批准号:2457809
-
项目类别:
-
资助金额:$32.34万
-
财政年份:1994
-
负责人:James MALLORY Musser
-
依托单位:
TUBERCULOSIS--DEVELOPMENT OF DNA BASED DIAGNOSTICS
-
批准号:2672414
-
项目类别:
-
资助金额:$33.63万
-
财政年份:1994
-
负责人:James MALLORY Musser
-
依托单位:
海外基金